Emergency contraception.

J. Klein
{"title":"Emergency contraception.","authors":"J. Klein","doi":"10.1542/9781610024358-part03-ch10","DOIUrl":null,"url":null,"abstract":"Research on the postcoital use of contraceptive steroids began in the 1960s. The first oral regimen, which used a widely available brand of combined estrogen–progestin oral contraceptive pills, was published in 1974 (7). Research on progestin-only regimens for occasional postcoital use by women having infrequent sexual intercourse also began at approximately the same time (8). Data regarding the use of IUDs as emergency contraceptives were initially published in the 1970s and, more recently, selective progesterone receptor modulators were introduced. The most commonly used oral emergency contraceptive regimen is the progestin-only pill, which consists of 1.5 mg of levonorgestrel (Table 1). This product can be purchased over the counter and is available without age restriction as of 2013. The product using two levonorgestrel doses of 0.75 mg has fallen out of use in favor of the simpler one-dose regimen, which is at least as effective as the two-dose product (9, 10). The levonorgestrel regimen is labeled for use for up to 72 hours after unprotected sex but is best used as soon as possible after unprotected sex (10–14) (Table 1). A second dedicated emergency contraceptive, a pill containing 30 mg of ulipristal acetate, was approved by the FDA in 2010 and requires a prescription. This selective progesterone receptor modulator, or antiprogestin, has demonstrated effectiveness up to 120 hours after unprotected sex (14) (Table 1). Combined estrogen–progestin emergency contraceptive regimens are no longer sold as a dedicated product. Emergency Contraception","PeriodicalId":75913,"journal":{"name":"Hospital practice","volume":"33 10 1","pages":"26"},"PeriodicalIF":0.0000,"publicationDate":"2020-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hospital practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1542/9781610024358-part03-ch10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Research on the postcoital use of contraceptive steroids began in the 1960s. The first oral regimen, which used a widely available brand of combined estrogen–progestin oral contraceptive pills, was published in 1974 (7). Research on progestin-only regimens for occasional postcoital use by women having infrequent sexual intercourse also began at approximately the same time (8). Data regarding the use of IUDs as emergency contraceptives were initially published in the 1970s and, more recently, selective progesterone receptor modulators were introduced. The most commonly used oral emergency contraceptive regimen is the progestin-only pill, which consists of 1.5 mg of levonorgestrel (Table 1). This product can be purchased over the counter and is available without age restriction as of 2013. The product using two levonorgestrel doses of 0.75 mg has fallen out of use in favor of the simpler one-dose regimen, which is at least as effective as the two-dose product (9, 10). The levonorgestrel regimen is labeled for use for up to 72 hours after unprotected sex but is best used as soon as possible after unprotected sex (10–14) (Table 1). A second dedicated emergency contraceptive, a pill containing 30 mg of ulipristal acetate, was approved by the FDA in 2010 and requires a prescription. This selective progesterone receptor modulator, or antiprogestin, has demonstrated effectiveness up to 120 hours after unprotected sex (14) (Table 1). Combined estrogen–progestin emergency contraceptive regimens are no longer sold as a dedicated product. Emergency Contraception
紧急避孕。
对性交后使用避孕类固醇的研究始于20世纪60年代。1974年发表了第一个口服方案,使用了一种广泛使用的品牌的雌激素-黄体酮联合口服避孕药(7)。大约在同一时间,也开始研究仅使用黄体酮的方案,用于性交不频繁的妇女偶尔的性交后使用(8)。关于使用宫内节育器作为紧急避孕药的数据最初发表于20世纪70年代,最近引入了选择性黄体酮受体调节剂。最常用的口服紧急避孕方案是单孕激素避孕药,含有1.5毫克左炔诺孕酮(表1)。该产品可在柜台购买,截至2013年,不受年龄限制。使用两剂0.75 mg左炔诺孕酮的产品已经不再使用,取而代之的是更简单的单剂量方案,其效果至少与两剂产品一样(9,10)。左炔诺孕酮方案被标记为在无保护的性行为后使用72小时,但最好在无保护的性行为后尽快使用(10-14)(表1)。第二种专用紧急避孕药,一种含有30毫克醋酸乌普利司妥的药丸,于2010年获得FDA批准,需要处方。这种选择性黄体酮受体调节剂或抗黄体酮已被证明在无保护性行为后120小时内有效(14)(表1)。雌激素-黄体酮联合紧急避孕方案不再作为专用产品销售。紧急避孕法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信